Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14.

L Pagan^{1

2}, C Yfanti¹, R Rijneveld¹, M Todd¹, P Jongste¹, J J Feijen¹, E S Klaassen¹, J N Bouwes Bavinck³, L Struijk⁴, M N C de Koning⁴, L Prestegarden⁵, T Niemeyer-van der Kolk¹, M I E van Poelgeest^{1

2}, R Rissmann^{1

6

7}

¹ Centre for Human Drug Research, Leiden, The Netherlands.
² Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands.
³ Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
⁴ Viroclinics-DDL, DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
⁵ Cytovation AS, Bergen, Norway.
⁶ Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
⁷ Leiden Skin Institute, Leiden, The Netherlands.

No abstract available

Publication types